The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1451
ISSUE1451
September 15, 2014
Efinaconazole Topical Solution (Jublia) for Onychomycosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Efinaconazole Topical Solution (Jublia) for Onychomycosis
September 15, 2014 (Issue: 1451)
The FDA has approved efinaconazole 10% solution
(Jublia – Valeant) for topical treatment of toenail
onychomycosis due to Trichophyton rubrum and/or
Trichophyton mentagrophytes. It is the first topical
triazole antifungal drug to be approved for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.